Metabolic & Weight Management
Cagrilintide
Amylin-receptor agonist studied for appetite regulation, often alongside GLP-1 agonists in combination research.
Appetite-regulation researchAmylin-pathway studiesCombination metabolic research
How it works in the body
Brain
Stomach
Pancreas
Adipose Tissue
RESEARCH USE ONLYINVESTIGATIONAL COMPOUNDAvailable following assessmentREGENEXA ASSESSMENT
Vial concentration
Cagrilintide
5 mgThis is a clinician-reviewed research peptide. Pricing is provided as part of an approved, personalized plan after your assessment is reviewed.
Not sure where to start?
Discover what may fit your goals — a short, personalized Regenexa Assessment.
Take Your Assessment →- 🔒 Secure & encrypted checkout
- 📦 Fast, discreet worldwide shipping
- 🧪 Pharmaceutical-grade quality
- 🔬 Research use only
Not sure where to start? Discover what may fit your goals — a short, personalized Regenexa Assessment.Take Your Assessment →
Long-acting amylin analog that slows gastric emptying and promotes satiety via a mechanism distinct from and complementary to GLP-1 agonism.
Receptors
Amylin receptor (calcitonin receptor / RAMP complex)
Half-life: Approximately 7 days, supporting once-weekly dosing.
Ask Regenexa AI about Cagrilintide
Get plain-language answers on mechanism, evidence and how it compares to other peptides — grounded in Regenexa's verified data.
“Can Cagrilintide be used alone?”Ask Regenexa AI →Available following assessmentTake Assessment
GLP-3 R
CagriSema
Survodutide
Mazdutide